Litcius/Paper detail

Endocytosis Inhibition in Humans to Improve Responses to ADCC-Mediating Antibodies

Hui Yi Chew, Priscila Oliveira de Lima, Jazmina L. Gonzalez Cruz, Blerida Banushi, G O Echejoh, Lingbo Hu, Shannon R. Joseph, Benedict Lum, James Rae, Jake S. O’Donnell, Lilia Merida de Long, Satomi Okano, Brigid King, Rachael Barry, Davide Moi, Roberta Mazzieri, Ranjeny Thomas, Fernando Souza-Fonseca-Guimarães, Matthew Foote, Adam McCluskey, Phillip J. Robinson, Ian H. Frazer, Nicholas A. Saunders, Robert G. Parton, Riccardo Dolcetti, Katharine Cuff, Jennifer Martin, Benedict Panizza, Euan Walpole, James W. Wells, Fiona Simpson

2020Cell188 citationsDOI

Topics & Concepts

EndocytosisAntibody-dependent cell-mediated cytotoxicityBiologyIn vivoMonoclonal antibodyCetuximabAntibodyEx vivoCell biologyCancer researchImmunologyCellBiochemistryBiotechnologyMonoclonal and Polyclonal Antibodies ResearchCAR-T cell therapy researchChronic Lymphocytic Leukemia Research
Endocytosis Inhibition in Humans to Improve Responses to ADCC-Mediating Antibodies | Litcius